- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
- S-1/A IPO registration
- 1.1 EX-1.1
- 3.1 EX-3.1
- 3.2 EX-3.2
- 3.3 EX-3.3
- 3.4 EX-3.4
- 4.2 EX-4.2
- 4.3 EX-4.3
- 5.1 EX-5.1
- 10.1 EX-10.1(A)
- 10.1 EX-10.1(B)
- 10.2 EX-10.2
- 10.3 EX-10.3
- 10.4 EX-10.4
- 10.5 EX-10.5(A)
- 10.5 EX-10.5(B)
- 10.5 EX-10.5(C)
- 10.6 EX-10.6(A)
- 10.6 EX-10.6(B)
- 10.6 EX-10.6(C)
- 10.7 EX-10.7
- 10.8 EX-10.8
- 10.9 EX-10.9
- 10.10 EX-10.10
- 10.11 EX-10.11
- 10.12 EX-10.12(A)
- 10.12 EX-10.12(B)
- 10.13 EX-10.13
- 10.14 EX-10.14
- 23.1 EX-23.1
- EX-FILING FEES Ex-filing Fees
- 13 Nov 23 424B4 Prospectus supplement with pricing info
- 13 Nov 23 EFFECT Notice of effectiveness
-
6 Nov 23 S-1/A IPO registration (amended)
- 1 Nov 23 S-1/A IPO registration (amended)
- 20 Oct 23 S-1 IPO registration
Exhibit 107
Calculation of Filing Fee Tables
Form S-1
(Form Type)
CARGO Therapeutics, Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered Securities
Security | Security Class Title | Fee Calculation Rule | Amount Registered | Proposed Maximum Per Unit | Maximum Aggregate Offering Price(1) | Fee Rate | Amount of Registration Fee | |||||||||
Fees to be Paid | Equity | Common stock, $0.001 par value per share | Rule 457(a) | 21,562,500 | $17.00(2) | $366,562,500(2) | $147.6 per $1,000,000 | $54,104.63 | ||||||||
Fees Previously Paid | Equity | Common stock, $0.001 par value per share | Rule 457(o) | — | — | $100,000,000(3) | $147.6 per $1,000,000 | $14,760.00 | ||||||||
Total Offering Amounts | $366,562,500 | $54,104.63 | ||||||||||||||
Total Fees Previously Paid | $147.6 per $1,000,000 | $14,760.00 | ||||||||||||||
Total Fee Offsets | — | |||||||||||||||
Net Fee Due | $39,344.63 |
(1) | Estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(a) of the Securities Act of 1933, as amended (the “Securities Act”). Includes 2,812,500 shares that the underwriters have the option to purchase to cover over-allotments, if any. See “Underwriting.” |
(2) | Calculated pursuant to Rule 457(a) of the Securities Act, based on an estimate of the proposed maximum aggregate offering price. |
(3) | Estimated solely for the purpose of computing the amount of the registration fee pursuant to Rule 457(o) under the Securities Act. |